Literature DB >> 19054498

The inhibitory effects of trastuzumab on corneal neovascularization.

Mete Güler1, Turgut Yilmaz, Ibrahim Ozercan, Tamer Elkiran.   

Abstract

PURPOSE: To investigate the effect of systemic administration of trastuzumab in the prevention of experimentally induced corneal neovascularization in a rat model.
DESIGN: An experimental animal study.
METHODS: Sixteen male Wistar-Albino rats weighing 250 g to 300 g were used in the study. Silver nitrate sticks (75% silver nitrate, 25% potassium nitrate) were used to induce chemical cauterization on the corneas of 16 eyes. The rats were randomized to 1 of 2 groups: Group 1 (n = 8) received intraperitoneally 1 ml (4 mg/kg) trastuzumab and Group 2 (n = 8) received 1 ml saline. The corneal surface covered with neovascular vessels was measured on the photographs as the percentage of the total area of the cornea by using computer imaging analysis on the eighth day. The corneas obtained from rats were evaluated for vascular endothelial growth factor (VEGF) immunostaining semicantitatively. The number of the corneal neovascularizations were also determined on slides. The results were evaluated with the Mann-Whitney U test.
RESULTS: The burn stimulus was similar between groups. The average neovascularization area in treatment group was statistically smaller than control (P = .008). The mean VEGF staining intensity of epithelial and endothelial layers of cornea in treatment group was less than control (P = .038 and P = .041, respectively). The stroma of the treatment group showed less staining, but the difference was not significant (P = .056). The number of corneal neovascularizations on slides in trastuzumab treated eyes were less than the control group (P = .02).
CONCLUSION: Systemic administration of trastuzumab is effective in prevention of the corneal neovascularization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054498     DOI: 10.1016/j.ajo.2008.09.022

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

Review 1.  Cytostatic drugs, neuregulin activation of erbB receptors, and angiogenesis.

Authors:  Nadia Hedhli; Kerry Strong Russell
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

Review 2.  Alternative Biomarkers for Combined Biology.

Authors:  Yong-Hyun Kim; Jennifer Kirsop; Wai Hong Wilson Tang
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

3.  The subconjunctival use of cetuximab and bevacizumab in inhibition of corneal angiogenesis.

Authors:  Selcuk Tunik; Yusuf Nergiz; Ugur Keklikci; Murat Akkus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-15       Impact factor: 3.117

4.  Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.

Authors:  Mary Putt; Virginia Shalkey Hahn; James L Januzzi; Heloisa Sawaya; Igal A Sebag; Juan Carlos Plana; Michael H Picard; Joseph R Carver; Elkan F Halpern; Irene Kuter; Jonathan Passeri; Victor Cohen; Jose Banchs; Randolph P Martin; Robert E Gerszten; Marielle Scherrer-Crosbie; Bonnie Ky
Journal:  Clin Chem       Date:  2015-07-27       Impact factor: 8.327

5.  Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab.

Authors:  Andreas S Barth; Yiqiang Zhang; Taosheng Li; Rachel R Smith; Isotta Chimenti; Ioannis Terrovitis; Darryl R Davis; Eddy Kizana; Alice S Ho; Brian O'Rourke; Antonio C Wolff; Gary Gerstenblith; Eduardo Marbán
Journal:  Stem Cells Transl Med       Date:  2012-04-10       Impact factor: 6.940

6.  Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer.

Authors:  Xiao-Feng Le; Maria I Almeida; Weiqun Mao; Riccardo Spizzo; Simona Rossi; Milena S Nicoloso; Shu Zhang; Yun Wu; George A Calin; Robert C Bast
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

7.  PEP-1-FK506BP inhibits alkali burn-induced corneal inflammation on the rat model of corneal alkali injury.

Authors:  Dae Won Kim; Sung Ho Lee; Min Jea Shin; Kibom Kim; Sae Kwang Ku; Jong Kyu Youn; Su Bin Cho; Jung Hwan Park; Chi Hern Lee; Ora Son; Eun Jeong Sohn; Sung-Woo Cho; Jong Hoon Park; Hyun Ah Kim; Kyu Hyung Han; Jinseu Park; Won Sik Eum; Soo Young Choi
Journal:  BMB Rep       Date:  2015-11       Impact factor: 4.778

8.  Proteomics-based evaluation of the mechanism underlying vascular injury via DNA interstrand crosslinks, glutathione perturbation, mitogen-activated protein kinase, and Wnt and ErbB signaling pathways induced by crotonaldehyde.

Authors:  Ming-Zhang Xie; Jun-Li Liu; Qing-Zu Gao; De-Ying Bo; Lei Wang; Xiao-Chun Zhou; Meng-Meng Zhao; Yu-Chao Zhang; Yu-Jing Zhang; Guo-An Zhao; Lu-Yang Jiao
Journal:  Clin Proteomics       Date:  2022-08-24       Impact factor: 5.000

9.  Corneal neovascularization: An enigma.

Authors:  Pulkit Gupta; Praveen K Malik; Hira Lal Gupta
Journal:  Oman J Ophthalmol       Date:  2013-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.